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ABSTRACT 
 
Hufgard, Jillian  
Applied Biology 
Rose-Hulman Institute of Technology 
February 2012 
Amebocyte Diameter and Density after Partial Exsanguinations in Limulus polyhemus 
Hemolymph 
William Weiner, Ph.D. 
 
The presence of endotoxins, a potentially life threatening bacterial contamination 
in medical devices and supplements, is determined by a product know as Limulus 
Amebocyte Lysate (LAL). The creation of LAL is known to raise the mortality rates of 
the crabs that are also seeing population declines due to environmental pressures and 
fishing industries. Because of the decline in the number of crabs, a method for the 
production of LAL, outside of the bleeding animals, is necessary. This research worked 
to quantify systematically the cell size, shape, and concentration of the amebocytes.  
After baseline data were collected, 40-50% of the hemolymph from six different 
animals was removed, and the recovery of the weight, amebocyte density, and diameter 
was regularly determined. Follow-up data showed the weight decreasing immediately 
after the large hemolymph removals, and recovery to baseline occurring within two 
weeks. Around day 8 after the large hemolymph removals, both the amebocyte density 
and diameter decrease. Between days 18 and 20 the density and diameter returned to 
normal, implying that new amebocytes can be seen in the hemolymph of a horseshoe crab 
about two weeks after a large hemolymph removal and the new cells will have a smaller 
diameter than the more mature amebocytes in the hemolymph.  
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1 BACKGROUND 
 
1.1 Introduction 
The presence of endotoxins, a potentially life threatening bacterial contamination in 
medical devices and medication, is determined by the Limulus Amebocyte Lysate (LAL).  
LAL is created by collecting hemolymph from the American Horseshoe Crab where the 
sole cell, the amebocyte, is separated and purified.  This lysate is highly sensitive and 
incredibly important with respect to the health industry, but the bleeding procedure is 
known to raise the mortality rates of the crabs up to 10%.1 The populations of these very 
important animals are declining because of environmental pressures and fishing 
industries, aside from the LAL industry. This population decline suggests that the need 
for an alternative production method is vital to the survival of the horseshoe crab. This 
research worked to answer a number of questions hindering the progress of finding an 
alternative LAL production method such as: the recovery of hemolymph volume after 
large hemolymph removals, amebocyte density, and amebocyte diameter in the 
hemolymph under normal conditions and straining conditions modeling amebocyte 
production in the gill lamellae where amebocytes are grown in-vitro.  
 
1.2 Endotoxins and the Human Reaction 
Endotoxins are the lipid-A portion of the lipopolysaccharides from the membrane 
of Gram-negative bacteria1. This ubiquitous endotoxin is only harmful to humans when 
coming into contact with the blood stream through drugs, medical devices, or rupturing 
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of the intestinal tract. When endotoxins are recognized by the human immune system, the 
hypothalamic system responds by raising the set point inducing fever2. This fever 
response becomes more detrimental to the human than the endotoxins because the 
temperature necessary to neutralize endotoxins is higher than the temperature of protein 
denaturing.  
The immune response to endotoxins, commonly known as endotoxemia or septic 
shock, can be characterized as “a state of inadequate tissue perfusion induced by 
microbial products and characterized by low blood pressure and biochemical signs of 
oxygen [deficiency]”2. Common symptoms of endotoxemia are fever with a raise in 
temperature of 1-2° C, myalgia, headache, nausea, chills, increased heart rate, and 
lowering of blood pressure2. As endotoxemia progresses, it can also cultivate symptoms 
of “reduced oxygen to vital organs, reduced nutrient transport capability to vital organs, 
generalized inflammatory response to vasodilatation, intravascular coagulation, renal 
failure, adult respiratory distress syndrome”, and ultimately death2. Recorded cases of 
endotoxemia reach 500,000 cases per year, with 35% being fatal2. Endotoxemia can be 
prevented by ensuring endotoxins do not come into contact with the human bloodstream. 
The established mode of this prevention is using LAL to test for sterile medical 
instruments and medication.   
 
1.3 Amebocytes and the Immune System of Horseshoe Crabs 
The LAL industry was founded through the research of Frederick Bang and Jack 
Levin who studied a 300 million year old species, the American Horseshoe Crab, which 
lives in an aquatic environment along the Atlantic Coast3.  Levin and Bang’s research 
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focused on the innate immunity of the horseshoe crab based on their hemolymph.  The 
hemolymph of the horseshoe crab consists of one main amebocyte: the granular 
amebocyte.  These amebocytes generate in the gills of the horseshoe crab and are ovoid 
in structure, non-adhesive to the surroundings, and are ~15-20 µm in diameter4.   
Since Gram-negative bacteria are ubiquitous to the horseshoe crab’s aquatic 
environment, endotoxins from the surrounding environment come in contact with the 
hemolymph whenever the horseshoe crab’s shell or soft tissue is broken 3.  The crab’s 
only defense against endotoxins involves the degranulation of the amebocyte.  This lysate 
binds to the endotoxins, thereby inactivating and immobilizing the endotoxins through 
clotting mechanisms5.  The coagulation acts as positive feedback encouraging other 
amebocytes to undergo degranulation forming a clot that neutralizes the endotoxins and 
rebuilds the barrier between the outside environment and the hemolymph.   
 
1.4 Current Endotoxin Testing Using Limulus Amebocyte Lysate 
Currently, the method for endotoxin testing is LAL, which is a serum made from 
the hemolymph of the American Horseshoe Crab6.  Harvesting the hemolymph of the 
American Horseshoe Crab and commercial production of LAL has become a $15,000 per 
quart industry; where one quart of LAL requires the bleeding of 15-20 animals7. The 
procedure for bleeding crabs has changed very little since being outlined in Levin and 
Bang’s original methods3. After the animals are bled the hemolymph and amebocytes are 
separated creating the lysate. The lysate is then freeze dried for storage or used 
immediately for endotoxin testing.   
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LAL testing is performed by mixing equal parts of the sample and LAL in a test tube 
which is incubated at 37° C for one hour8. After incubation, the test tube is completely 
inverted. The solution will clot in the presence of endotoxins, but will remain liquid if no 
endotoxins are present. This method provides sensitivity levels up to 3 picograms of 
endotoxins and is known as the gel clot method8.  
 
1.5 Limulus Amebocyte Lysate Challenges 
The American Horseshoe Crab population experienced a steady decline over the 
last three decades due to many factors such as the LAL industry, depletion of their 
environment, natural predators, and being harvested for bait and fertilizer. In a five year 
period, the bait industry alone decreased the horseshoe crab population from 1.2 million 
to around 100,000, which is detrimental to their industry and the crabs3. The depletion of 
the horseshoe crab population not only affects the LAL industry but also harms the Red 
Knot, which rely on crab eggs as their sole food source during migration3. Throughout 
history, the presence of Red Knots did not threaten the horseshoe crab population, but 
other factors have caused the amount of crab eggs the birds are eating to be debilitating to 
the population.    
The necessity and expense of producing LAL has gradually increased over the 
years causing another pressure on the animals and the product. Over an eight year period 
the number of crabs bled for the LAL industry went from 127,000 to 240,0008. As the 
industry continues to grow, the amount of hemolymph necessary increases. Which 
implies that the number of animals bled also increases, putting a strain on the animals 
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especially if they were previously bled or are injured? Bleeding protocols have been 
placed to protect the animals, but in 2006 over 300,000 crabs were harvested and over 
4,600 were rejected although a significantly larger percent of the population was unfit to 
be bled9. Because of the importance of the industry to the medical field, the population of 
American Horseshoe Crabs and the prosperous LAL industry need to be protected. 
 
1.6 Previous Research Attempts 
Because of the decline in population accompanied by the demand for horseshoe 
crabs, alternate testing for endotoxins or forms of producing LAL has become important.  
Thus far, no other aquatic or land animal is well suited for endotoxin testing; suggesting, 
alternative methods for LAL production should be attempted. Research was attempted to 
synthesize LAL from one of the three proteins that neutralize endotoxins; this synthetic 
peptide is more expensive and less sensitive than LAL making this artificial option 
unrealistic8.  Another research project attempted was “The In Vitro Cultivation of 
Limulus Amebocytes” which utilized various medias trying to create a protocol for long 
term maintenance of hemolymph5. Three month cultures of hemolymph with frequent 
media changes were completed5. Culturing of amebocytes via a nutrient mist bioreactor 
was attempted, but abandoned because of the difficulty of having an endotoxin free 
environment10.  The “In Vitro Production of Amebocytes from Tachypleus Gigas in 
Leibovitz Culture Medium”, patent outlines a procedure used on the Indian Horseshoe 
Crab which cultures the gill flaps for up to 90 days, at time of publication11.  The 
successful cultures via the Indian Horseshoe Crab have allowed for a means to culture the 
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gills and harvest amebocytes in the American Horseshoe Crab, which would allow for 
producing LAL without the frequent harvesting of crabs.   
Since 2006 two students from Rose-Hulman Institute of Technology have 
performed original research and published theses regarding the American Horseshoe 
Crab.  Amber Brannan generated a detailed protocol for creating an endotoxin free 
environment and successfully produced cultures of the gill lamellae for ten weeks12.  Kirk 
Thompson built off of Amber Brannan’s work and developed a protocol for staining 
amebocytes to test for the presence of amebocytes in the cultures of gill lamellae.  His 
research provided photographs and descriptions that suggested the presence of 
amebocytes in cultures 22 days old13.  Brannan and Thompson’s research both suggested 
that amebocytes were present in the cultures but neither were able to confirm them. The 
primary objective of this research is to identify characteristics of amebocytes present in 
hemolymph for comparison to amebocytes grown in in-vitro cultures. To create a profile 
of the amebocytes, the following three criteria were taken into account: changes in 
hemolymph volume following large hemolymph removals, average amebocyte density, 
and average amebocyte diameter.  
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2 RESEARCH OBJECTIVES 
 
2.1 Establishment of Baseline Data 
 The horseshoe crabs’ baseline information is obtained for comparison to animals 
under various conditions and stresses. The literature suggests the average sized animal 
has amebocytes averaging 15-20 µm, but the literature does not provide any information 
on the possible amebocyte density in an average animal4. These baseline data give an 
accurate representation of the weight, amebocyte density, and amebocyte diameter of 
each animal under normal conditions. 
 
2.2 Large Hemolymph Removals 
 After the collection and subsequent profile development of amebocytes for each 
test animal, a series of large blood removals can be performed. The literature suggests 
that each animal can be safely bled 50 +/- 13 % of their total hemolymph volume14. By 
removing a significant amount of hemolymph it can be determined how these bleeds 
affect the amebocyte density and size, as well as how long it takes for each parameter to 
return to its baseline levels. 
 
2.2.1 Weight, Amebocyte Density, and Amebocyte Diameter Recovery  
  Current literature suggests several methods for estimating the volume of 
hemolymph in each animal. One of these possible methods uses the wet weight of the 
animal to estimate the hemolymph volume.  By monitoring the weights of the animals 
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before and after large hemolymph removals the volume of hemolymph in the animal can 
be estimated, giving a mode for monitoring the hemolymph recovery of the animal.  
While monitoring the recovery of the animal’s hemolymph volume, the 
amebocyte density can be calculated by taking small amounts of hemolymph at 
designated intervals providing insight into changes in amebocyte density.  
 The small hemolymph removals also allow for profiles of the amebocyte diameter 
to be made. The amebocyte profiles in relation to the change in amebocyte density will 
provide information on when new amebocytes are being added to the blood, as well as 
how the size of these amebocytes compare to their average size. By monitoring all three 
criteria simultaneously a better understanding of how the amebocytes behave in the 
hemolymph will be established which provides a reference with which to compare 
amebocytes cultured in-vitro.    
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3 METHODOLOGY 
 
 Both investigators, Amber and Kirk, worked on a protocol for gill lamellae 
culturing and were confronted by the issue of how to confirm the growth of new 
amebocytes. This challenge was the motivation for this research which delves into the 
amebocytes naturally present in the Limulus Polyhemus hemolymph. The Effect of 
Hemolymph Extraction Volume and Handling Stress on Horseshoe Crab Mortality by 
Lenka Hurton provided useful insight into determining the total hemolymph volume in 
each animal. The American Horseshoe Crab by Jack Levin also provided information in 
the form of a possible mode for slowing degranulation of amebocytes. Through the 
guidance of these and other works, I was able to establish a conceptual basis and an 
understanding of the complexity of the research. The remainder of this section outlines 
the reasoning and actions necessary for completion of the research.  
 
3.1 Tank and Water Maintenance 
 After ordering and the arrival of ten horseshoe crabs from the Marine Biological 
Laboratory (Woods Hole, MA) all packing material was removed from the surface of the 
animals, and they were placed in a 75 gallon salt water sand bottom tank. The water in 
the tank was kept at a specific gravity between 1.020 and 1.024, by testing it weekly with 
a hydrometer, and 21-27 °C. An aerator, filter, and fecal matter remover were also 
present to provide sufficient oxygen and maintain a clean environment. Three gallons of 
deionized water were added about once a week or as the water levels decreased and 
Instant Ocean® was added when the salinity dropped below the ideal range. Every 10-12 
weeks ten gallons of water was changed and the salinity was corrected as necessary.  
14 
 
 
Figure 1. Schematic of a horseshoe 
crab; red dots correspond to 
locations where holes can be 
drilled to differentiate the animals.   
3.2 Feeding the Animals 
 After monitoring the weight of the animals and consulting with Shannon Tieken 
regarding proper animal care procedures, the animals were placed on a two week feeding 
cycle; this schedule minimized disturbances to the data collection process. Frozen 
seafood was defrosted in deionized water and fed to the animals outside of the tank in 
order to preserve the cleanliness of the water. One at a time the animals were removed 
from the tank, laid on their backs, and a piece of food was placed in their mouth. If the 
animals finished the piece of food they were given another. After giving them sufficient 
time to eat they were returned to the tank.     
 
3.3 Distinguishing Animals from One Another 
 When ordering horseshoe crabs, the males are shipped more often because of their 
smaller size compared to the females. Since all of the animals were of similar size, a 
mechanism for identifying each animal was necessary. A commonly used technique calls 
for boring holes using a small bit drill into the carapace of 
the animals. Each of the ten animals were assigned a 
specific number of holes in a unique pattern or area to 
insure the animals could be distinguished from one 
another. The holes were drilled in areas of the animal’s 
carapace that would not cause pain or infection.  
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3.4 Endotoxin Removal and Sterile Techniques 
 An endotoxin free environment is essential to work with hemolymph and 
subsequent amebocytes from the Limulus polyhemus. The sensitivity of the amebocytes 
causes them to begin clotting as soon as they come in contact with a non-sterile surface or 
the air, which is contaminated with endotoxins. Amber Brannan provided a set of 
protocols for rendering an endotoxin free environment which were slightly adapted for 
this research12. 
 
3.4.1 Endotoxin Removal from Storage Vials 
 Amber Brannan originated this method through the aid of a Sigma E-TOXATE 
kit for the preparation of her metal and glass equipment. After careful assessment of all 
equipment necessary it was determined that the majority could be purchased in 
individually wrapped sterile containers, with the exception of glass storages vials. A large 
quantity of 8 mL and a few 100 mL glass vials would be used to store collected blood and 
pre-made solutions. These vials were expensive to purchase separately, so Amber 
Brannan’s procedure was used for the sterilization of glass. A 1% alkaline detergent 
solution was made using Alconox Liqui-Nox and deionized water in a 2-gallon 
polypropylene lidded bucket. All lids and glass vials were added to this bucket and 
soaked for a minimum of 24 hours. Wearing nitrile gloves, each vial was removed from 
the soak solution and rinsed with deionized water. The lids were then removed because 
the rest of the procedure would damage their rubber lining. The vials were then 
transferred to sheets of aluminum foil and heated in a hot air oven at 175°C for 10 
minutes. Upon removal from the oven they were wrapped in aluminum foil and placed in 
16 
 
 
Figure 2. Particle board and 
rubber strap used to hold the 
animals in place during bleeding. 
an autoclave at 121°C for 1 hour. Once the autoclave cycle was complete they were 
immediately transported back to the hot air oven for 3 hours. Upon completion of the 
process the vials were left to cool in the aluminum foil before the lids were tightly 
screwed on for storage in cardboard boxes.  
 
3.4.2 Treatment of Non-sterile Equipment 
 Before the data collection process began, it became clear that the blood could not 
be collected and processed in an endotoxin free environment, but the amount of 
contamination to the hemolymph needed to be minimized. The hemacytometer used in 
the data collection process was cleaned before and after every use with deionized water 
and Kimwipes to eliminate as much contamination as possible. The time between 
hemolymph removal and data collection was less than three minutes which allowed for 
sufficient time to photograph the amebocytes before endotoxins induced degranulation.       
 
3.5 Hemolymph Removal Apparatus 
A piece of particle board was cut to a width of 
sixty-one centimeters; the animals were folded in half 
along their hinge and placed on the board with their eyes 
facing upward. From here a rubber bungee cord was 
attached to either side of the board, holding the animals 
in place. The size of the board and the bungee cord 
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assured the animals were secure enough to restrict their movement but not so secure as to 
injure the animals. This allowed for the investigator to draw the hemolymph without the 
assistance of another person holding the animal in place.      
 
3.6 Pre-Hemolymph Removal Animal Preparation 
Pre-hemolymph removal protocols were established to estimate the volume of 
hemolymph removed and ensure animal health. Prior to bleeding, each animal was 
weighed in a bucket on a scale. The animal’s wet weight was recorded. To ensure water 
on their bodies was not significantly affecting their weight they were allowed to drip until 
all excess water was removed. These weights were recorded for hemolymph volume 
estimates; which provided insight into each animal’s health, eating habits, and 
hemolymph recovery after large hemolymph removals. Animal weights ranged from five 
hundred to eight hundred grams. Hemolymph removal utilized a syringe puncturing the 
soft tissue of the hinge, much like blood removal from a human, which means a puncture 
remains after the syringe is removed. For the safety of the animals, the soft tissue and 
surrounding shell was cleaned with Kimwipes and a 95% alcohol blend. This procedure 
minimized puncture site infections promoting better overall health of the animals. 
 
3.7 Hemolymph Removal 
 For the safety of the animals, sterile techniques and equipment were necessary. 
These techniques also assured the best results for hemolymph collection. Since there was 
little literature providing insight into a hemolymph removal protocol, a series of test 
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Figure 3. Horseshoe crab folded at 
the hinge exposing an area of soft 
tissue which leads to the tubular heart. 
hemolymph removals was performed. The following protocols minimized the amount of 
damage done to the animal’s soft tissue without compromising the hemolymph samples.   
 
3.7.1 Large Hemolymph Removals 
 The literature suggested the following equation for estimating the total 
hemolymph volume in an animal of a specified wet weight: 
  ܸ ൌ 257.2 ∗ ݓ െ 5.693 where V = volume (ml)  w = weight (kg)14. 
 Once the total hemolymph volume was determined, the appropriate percentage to 
be removed was calculated. In the case of the large bleeds, an 18 gauge needle was used 
without a syringe. The needle was inserted through the soft tissue of the animal into the 
tubular heart where the beating of the animal’s heart 
caused the hemolymph to flow freely into a collection 
vial. This method provided less stress on the animal by 
eliminating the vacuum pressure which is associated 
with using a syringe. After hemolymph removal the 
animals were weighed again along with the container of hemolymph to estimate the 
volume of hemolymph removed. The animals were then immediately returned to their 
tank for recovery.     
 
3.7.2 Small Hemolymph Removals 
 The small hemolymph removals consisted of removing 1 mL of hemolymph 
originally, but after initial testing the removal of 0.5 mL of hemolymph proved to be 
sufficient for analysis purposes. The 0.5 mL of hemolymph removal amounts to between 
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0.25 and 0.5% of the animal’s total hemolymph volume. Similar to the large hemolymph 
removals, the animals were pierced with a needle through their soft tissue into their 
tubular heart and were returned to the tank immediately after hemolymph removal. The 
small hemolymph removals differed by using a 26 gauge needle which created a smaller 
puncture hole while still allowing for the amebocytes to be collected. The small 
collections also utilized a syringe which allowed for a precise volume of hemolymph to 
be collected.  Originally when 1 mL of hemolymph was being collected, it was separated 
into two sterile glass vials, one in which an equal amount of the anti-clotting solution was 
present. These bleeds were continued for ninety days to monitor the change in density 
and diameter of the amebocytes. 
Table 1. Over the duration of the bleeding series, the number of bleeds per week was decreased to 
minimize the number of puncture wounds on the animal while allowing for sufficient data collections. 
Week Number of bleeds per week 
1 13 
2 5 
3-9 3 
9-12 2 
 
3.8 Photographic Documentation of Amebocytes 
 Since the amebocytes present in hemolymph samples are susceptible to 
degranulation in a short amount of time, it was necessary to find a way to collect data 
before the amebocytes degranulated. The DinoCapture 2.0 system was used, which 
consisted of a camera inserted into the eyepiece of a standard microscope connected to a 
computer. The camera allowed for pictures to be taken of the amebocytes on glass slides 
or on hemacytometers for later analysis.   
 Immediately after hemolymph removals, the animals were returned to their tank 
and the vial or syringe was taken to the microscope for analysis. Here a hemacytometer 
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was filled on both sides via the syringe or a sterile micropipette. The hemacytometer was 
placed on the microscope stage and pictures were captured at optical magnifications of 
5X, 10X, and 40X with the eye piece adding 10X magnification. Each set of pictures 
captured at least fifty amebocytes for adequate sample size and both sides of the 
hemacytometer provided a self check if a data set showed an anomaly. A series of time 
lapse photographs and videos were taken to observe the process of degranulation.       
 
3.9 Data Collection 
 Photographs were used to estimate the amebocyte density per milliliter of 
hemolymph as well as to observe the amebocyte diameter before and after large 
hemolymph collections. The videos and time lapse photography were taken when the 
protocol was initially being developed at one or five minute intervals for thirty minutes to 
two hours to observe the rate and process of degranulation. These time lapse data 
provided information about how long hemolymph could be exposed to endotoxins before 
degranulation of amebocytes occurred appreciably.  
 
3.9.1 Amebocyte Density per Milliliter of Hemolymph 
The hemacytometers used were comprised of nine square 1.0 mm2 boxes; within 
the center one mm box was twenty five 0.4 mm2 boxes. Theses 0.4 mm2 boxes were 
further subdivided into sixteen 0.0025 mm2 boxes. The depth of fluid held by 
hemacytometer was 0.1 mm. When using the 10X magnification on the microscope, six 
of the 0.4 mm2 were visible and all amebocytes within this area could be counted. A 
random number generator was used to select six of the 0.4 mm2 boxes in which all 
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Figure 4. Hemacytometer showing the 0.4 
mm2 boxes, five which are blackened, with 
16 smaller boxes within each. 
amebocytes were counted. Amebocyte densities were calculated using the following 
equation: 
 ஺௠௘௕௢௖௬௧௘௦௠௟ ൌ #݋݂	݈݈ܿ݁ݏ	ܿ݋ݑ݊ݐ݁݀	 ൈ ሺ25 ൈ 10 ൈ 1000ሻ	   
 Cell counts are generally performed by 
counting all cells in one 1.0 mm2 box, this number 
is then multiplied by 10 to find the number of 
cells/mm3 and then by 1000 to find cells per ml. In 
this case only six of the 0.4 mm2 boxes were 
counted; therefore, the counted amebocytes were 
not only subjected to the normal protocol but also multiplied by twenty-five since there 
are twenty-five 0.4 mm2 boxes within a 1.0 mm2 box. Since six boxes were counted and 
subjected to the same method for determining amebocytes/ml the average was taken and 
used as the value for that sample.  
 
3.9.2 Amebocyte Diameter Profiles 
 After further exploration into the DinoCapture 2.0 program a measurement 
feature was found; this feature allowed for three point circles to be made around fifty 
amebocytes and then the program would calculate the diameter. DinoCapture 2.0 utilized 
an input of the magnification along with the measurement of an already known area, 
which in this case was the outline of a box from the hemacytometer, to convert the 
measurement to actual diameter. This data was then transferred directly to Microsoft 
Excel where further calculations were performed and compared to other data collections.          
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3.10 Statistical Analysis 			
  After the data collection and processing a series of statistical tests can be 
performed to better understand the trends being observed. Unstacked one-way ANOVA 
tests were used for comparing days of a hemolymph removal series to another and for the 
comparison between different animals. If statistically significant variation exists within or 
between animals, post-hoc testing was performed using Tukey grouping. This post-hoc 
test organizes the data in groups that are statistically similar. Similar Tukey groups are 
identical using a letter scheme, meaning that a series designated as “group A” are similar 
to one another but dissimilar to those in “group B”. Some data points may be in 
overlapping groups. When comparing day data points after the large hemolymph removal 
to the baseline data, one-sample t-tests with a hypothesis were used to test for statistically 
significant deviation from the baseline mean.   
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 4 RESULTS	
 
4.1 Analysis of Baseline Data 
The baseline data collected over two weeks provided the mean weight, amebocyte 
density, and amebocyte diameter for the eight animals as summarized in Table 2 Four 
separate bleeds were conducted on different days and each bleed was compared to 
determine the sampling error.  For each animal, the weight varied no more than two 
percent from the mean for any given day. Figure 5 shows the animal with the least 
variation between days and the animal with the most variation between days for both 
amebocyte density and diameter. Data for the remaining animals can be found in 
Appendix B. When comparing between animals, there is up to 60% variation for the 
density and up to 19% variation for the diameter (Table 7,12).  
Table 2. Baseline data collected from eight animals over a two week period providing insight into the 
animals average amebocyte diameter, density, and hemolymph volume prior to treatments. Standard 
deviations are given in parenthesis.  
Animal Weight(g) Amebocyte density 
(amebocytes x 107/ml) 
Amebocyte diameter(µm) 
1 524(7.2) 1.98(0.4) 11.02(1.54) 
2 536(3.5) 2.34(0.6) 10.48(1.69) 
3 539(4.2) 1.09(0.3) 9.55(1.84) 
4 577(7.1) 1.71(0.5) 11.52(1.52) 
5 635(6.9) 1.81(0.3) 11.68(1.81) 
6 657(3.0) 1.51(0.5) 9.49(1.58) 
7 676(7.1) 2.85(0.7) 9.85(1.77) 
8 782(5.5) 2.25(0.4) 10.86(1.75) 
Average 616(89.1) 1.93(0.7) 10.53(1.87)  
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Figure 5.  The yellow point indicates the mean generated from all data collected in the baseline series. 
(Left) The first bleed in the baseline data for Animal 8 has a significantly different (p ≤ 0.05) density then 
the remaining three hemolymph draws. (Right) Animal 2’s amebocyte density for all four days are 
statistically similar (p = 0.59) showing little variation between the four bleeds making up the baseline 
density value. 
 
 
Figure 6. (Left) Animal 8’s amebocyte diameter over the four bleeds in the baseline the second day was 
statistically different (p ≤ 0.05) than the others. (Right) Animal 3’s amebocyte diameters in four separate 
bleeds are statistically similar to one another (p = 0.101).    
 
4.2 Large Hemolymph Removals 
 
4.2.1 Weight 
Immediately following the large bleeds, the animals were weighed along with 
their respective vials of collected hemolymph. The mass lost and the mass of the 
hemolymph removed are recorded in Table 3 which illustrates the variability between the 
two values. Additionally, animals were weighed every subsequent hemolymph removal 
to monitor the rate of hemolymph volume recovery. Figure 7 shows each animal’s weight 
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decreased between two and nine percent of the animal’s baseline weight after the initial 
bleed and recovered to within two percent of the baseline mean by eight days into the 
series. The weight of each animal after recovering stabilizes to within two percent of the 
baseline for the remainder of the experiment.   
Table 3. The difference in wet weights for each animal before and after the large hemolymph removal 
approximately corresponds to the amount of hemolymph removed. 
Animal Weight 
Change (g) 
Hemolymph 
Removed (g) 
Hemolymph 
Removed(ml) 
1 34 51 58 
2 62 51 53 
3 62 57 70 
4  90 68 74 
5 80 68 63 
6 74 68 67 
 
Figure 7. All six animals experienced a significant drop in their weight after the initial large bleed but saw 
an increase and return to withing five precent of their baseline weight within eight days. 
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4.2.2 Amebocyte Density 
For each subsequent hemolymph draw the density was calculated showing a common 
pattern between five of the six animals. [The sixth animal died of unknown causes the 
day after the large hemolymph removal.] The pattern observed in the five animals was a 
significant decrease in density within the first week of the series with p-values ≤ 0.05. 
The density returned to the baseline mean within three weeks of the initial decrease with 
p-values ≥ 0.05. A second decrease was seen in all five animals, with unknown causation. 
 
Figure 8. The mean and standard deviation of the amebocyte density data for Animal 4 suggests the 
density dropped below the baseline value at day three and returned to the mean baseline at day eighteen. 
Table 4. Animal 4’s mean amebocyte density decreases below the baseline on day three and the mean 
density returns to the baseline average at day eighteen with p-values ≤ 0.05 confirming a statistically 
significant change. N = 6 for each day. 
Time (days) 
Mean Density 
(amebocytes x 107/ml) StDev SE Mean P 
Baseline 1.71E+07 5.41E+06 9.02E+05 1.00 
3 5.29E+06 3.03E+06 1.24E+06 0.00 
5 8.00E+06 1.69E+06 6.89E+05 0.00 
8 4.88E+06 3.58E+06 1.46E+06 0.00 
11 9.58E+06 2.15E+06 8.80E+05 0.00 
14 1.05E+07 4.01E+05 1.64E+05 0.00 
18 1.58E+07 2.60E+06 1.06E+06 0.26 
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4.2.3 Amebocyte Diameter 
The pattern seen in Animal 4’s amebocyte profile (Figure 11) is representative of 
three of the other animals whose amebocyte profiles are included in Appendix B. Animal 
4 shows a change in diameter distribution three days after the large hemolymph removal, 
with a wider range of diameters and a smaller mean (p-values ≤ 0.05). The next five 
samples also show a larger range in distribution and a smaller mean, but they begin an 
upward trend toward the baseline mean value. On day fourteen, the mean diameter 
returns to the mean baseline value with p-values ≥ 0.05.  
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Figure 9. After the initial large bleed, Animal 4’s mean amebocyte diameter decreases below the baseline 
mean at day three and returns to the baseline mean at day fourteen. 
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Figure 10. Animal 4’s amebocyte diameter decreases below the baseline mean at day three followed by an 
increase back to the mean at day fourteen. The diameter remains statistically similar size to the baseline 
mean for the remainder of the experiment (p ≥ 0.05).  
Table 5. After the initial large bleed, Animal 4’s mean amebocyte diameter decreases below the baseline 
mean at day three and returns to the baseline mean at day fourteen with corresponding p ≤ 0.05 showing a 
statistically different mean diameter. 
Time (days) N Mean Diameter (µm) StDev SE Mean P 
Baseline 300 11.52 1.52 0.09 1.00 
3 100 9.40 1.68 0.17 0.00 
5 51 9.77 1.42 0.20 0.00 
8 51 8.80 1.82 0.25 0.00 
11 51 8.91 1.66 0.23 0.00 
14 51 11.06 1.60 0.22 0.05 
18 51 11.34 1.46 0.21 0.39 
 
4.3 Amebocyte Viability Time Frame 
The time lapse photographs and videos of the amebocytes taken from multiple 
samples on separate days provided an idea of the rate of amebocyte degranulation. The 
photographs, which were taken between 45 seconds and 90 seconds after hemolymph 
removal, showed minimal amebocyte degranulation beginning immediately after initial 
viewing and being fully degranulated after about an hour. The videos showed the 
amebocytes moving through the hemolymph towards one another and creating large clots 
of degranulated amebocytes. These data suggest that as long as photographs are collected 
within three minutes after exposure to air, then no significant degranulation will have 
occurred yet. 
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5 DISCUSSION 
 
5.1 Amebocyte Density and Size 
The baseline analysis of amebocyte density and size showed statistically 
significant variability between certain days for all of the animals studied. The day in 
which the amebocyte density varied was not always the same day in which the amebocyte 
diameter differed. Because the variation in amebocyte density and size is not occurring 
on the same day, suggests some sampling error may be occurring or some uncontrolled 
mechanism within the animal may be present. If a sample began clotting or the 
amebocytes were not evenly distributed across the hemacytometer then the data will be 
skewed. Clotting may have been induced at different rates if the needles, syringes, and 
hemacytometers had differing amounts of endotoxins present. The variation in amebocyte 
densities within animals also may be attributed to the natural fluctuation in the life cycle 
of amebocytes in the hemolymph. Draws may have been taken on days where 
amebocytes were being released at higher quantities, skewing the density in the upper 
direction. The animals also may have experienced encounters in the tank that caused 
injury or stress, thereby decreasing the amebocyte density.  
Since the change in amebocyte diameter did not occur on the same day as the 
density changes, the difference in diameters may be attributed to a number of different 
complications or unknown animal mechanisms. The computer program used to calculate 
diameter used discrete sizes, which explains the gaps in the amebocyte diameter data seen 
in Figure 9 (between eight and ten µm). Aside from the computer program, the 
amebocytes may not be evenly distributed by size in the hemolymph. For instance, the 
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smaller amebocytes may remain closer to the gill lamellae for longer amounts of time or 
the larger amebocytes may move slower causing them to congregate in certain areas. The 
hemolymph was drawn directly from the tubular heart in attempt to best capture a range 
of amebocytes in the circulating hemolymph. Although one day of the baseline data may 
have varied from the other three, the aggregate data provide a representation of 
amebocyte density and size.  Because of the variation within and between the animal’s 
future researchers should be cautious when interpreting the data from a single draw; 
instead taking multiple samples for one single day or looking at trends over time would 
be preferable given this significant variation. 
 
5.2 Analysis of the Animals after Large Hemolymph Removals 
 
5.2.1 Weight Recovery 
After the initial large hemolymph removal, the weight of the animals dropped 
immediately. However, recovery was exhibited within hours, suggested by the increase in 
weight three and six hours after the large hemolymph removal. This immediate recovery 
likely occurred because the animal’s sequestered water from the tank to replace the 
hemolymph volume removed. This water sequestration is common in many aquatic 
animals, allowing for the organisms to regulate their volume and ion concentrations. The 
animals all saw a complete recovery of their weight within two weeks. The normal 
feeding schedule was not disrupted by the large hemolymph removal because the 
animal’s weights recovered prior to the scheduled feeding, and thus, feeding is not the 
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reason for the return to baseline weight. Throughout the remainder of the experiment the 
animal’s weights fluctuated up to ten grams in either direction, most likely because of the 
animal’s metabolism.  
The difference between the weight of the animals before and after the large 
hemolymph removal was compared to the weight of the hemolymph removed.  Although 
in each case the value in grams varied, the discrepancy can partially be explained by the 
presence of water on the animals. The equation used to estimate the hemolymph volume 
of the animals took into account their wet weight, but the process of weighing, bleeding, 
and reweighing each animal spanned ten to fifteen minutes. This time outside of the 
water was sufficient to allow the salt water to drip off the animals or evaporate, slightly 
altering its weight. For a more accurate reading of the change in weights, the animal 
could be left out of the water for ten minutes before the initial weighing. Although there 
was a difference in the weight of the hemolymph removed and the weight change in the 
animal, the hemolymph volume equation is still a reliable method for estimation. Also 
noteworthy, the grams and milliliters of hemolymph removed show a near one-to-one 
relationship explained by a significant portion of the hemolymph being water (which also 
has a one to one ratio between milliliters and grams). By weighing the animals and using 
the equation that relates animal weight to hemolymph volume, the hemolymph volume 
can be estimated. Thus, hemolymph recovery from water sequestration after large 
hemolymph removals can be monitored.       
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5.2.2 Amebocyte Density Recovery 
Assuming these aquatic animals take in water from their environment to 
compensate for the large hemolymph loss, a decrease in amebocyte density is expected 
when animal weight first begins to recover. The same trend in weight increase and 
amebocyte density decrease was seen in all five of the surviving animals. As shown in 
Figure 11, Animal 4’s weight returned to normal the same time the amebocyte density 
began dropping, ultimately to forty percent of the baseline value. The decrease in 
amebocyte density is mostly likely due to the animal replacing its lost hemolymph with 
water; which explains both why the animal’s weight recovered as well as why amebocyte 
density decreased. After the amebocyte density bottomed out at forty percent of the 
baseline value it increased over a two week period to a statistically similar amebocyte 
density within ten percent of the baseline value. This increase in amebocyte density may 
have been caused by the gill lamellae generating new amebocytes and releasing them in 
the hemolymph.   
 
Figure 11. Percentage of animal weight and amebocyte density (from the baseline) following the large 
hemolymph removal shows the amebocyte density began to decrease in Animal 4 at the same time that its 
weight recovered. 
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The animals that died throughout the series showed a steady decrease in 
amebocyte density two weeks prior to death, which suggests that amebocyte density may 
provide a measure of the animals overall health. The cause of death for each animal that 
died during the series is unknown, especially since animals who were not subjected to 
large hemolymph removals or the follow up series also died. Their deaths suggest 
something other than the hemolymph removals was playing a factor. The large 
hemolymph removals may have played a role in lowering the immune system of the 
animals causing them to die. However, since the animals died at various times, there is no 
way of knowing their exact cause of death. This study suggests that after a large 
hemolymph removal the amebocyte density will recover to within ten percent of the 
baseline value within three weeks, suggesting gill lamellae being cultured should be 
monitored for amebocyte growth two to four weeks after culture initiation.  
 
5.2.3 Amebocyte Diameter Recovery 
The increase in amebocyte density observed and discussed above can be 
explained two ways: the hemolymph sans amebocytes was being removed from the 
animals or the gill lamellae were releasing new amebocytes into the hemolymph system. 
Evidence for the second reason is proposed when looking at the amebocyte profile over 
time, specifically the diameter. If the amebocyte density was increasing because of the 
production of new amebocytes, a larger proportion of smaller amebocytes should be 
present, which is consistent with what is observed. The literature suggests that new 
amebocytes are smaller than fully mature and degranulating amebocytes.15, 16 Following 
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this decrease in diameter, the mean diameter returned to its baseline within a week, 
possibly suggesting the new amebocytes matured and grew in the hemolymph.  
  Large hemolymph removals caused a statistically significant drop in the 
amebocyte density, but amebocytes still remained in the hemolymph after 40-50% of the 
hemolymph was removed. These remaining amebocytes mask the change in mean 
diameter as new amebocytes are released. This challenge was compensated for by not 
only looking at the mean diameter, but also by observing the distribution of amebocyte 
diameters in each subsequent hemolymph draw. When the mean diameter shifted, the 
distribution of amebocyte diameters also changed from that seen in the baseline data. 
Figure 12 shows this trend on days three through eighteen, with a change in the 
distribution of diameters from the baseline correlating with the same time as the density 
changes. The change in amebocyte density, lowered mean diameter, and change in the 
distribution of the amebocyte diameters suggests noticeable amounts of new amebocytes 
were being released into the hemolymph.  As the amebocyte density was decreasing the 
gill lamellae were releasing amebocytes into the hemolymph at the same rate as when the 
animals are healthy. Because of this release of amebocytes and the decreased density of 
mature amebocytes the diameter drops below the baseline mean as the density is 
decreasing. As the density began increasing the mean diameter decreased further, from 
~9 µm to ~8 µm, also showing the production of new amebocytes. When the animal 
experiences a large decrease in amebocyte density, the gill lamellae may be up-regulating 
amebocyte production to compensate. Over the remainder of the experiment, the 
amebocyte profiles may have revealed a steady-state between the rate of amebocyte 
renewal and death; evidenced by the similar mean diameter and distribution. When 
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looking at gill lamellae cultures two to three weeks after initiation, new amebocytes will 
have an average diameter between six and ten µm. After initial confirmation of 
amebocyte production, the amebocytes will begin growing and maturing reaching an 
average size of ten to fifteen µm around day twenty for animals between 500-800 grams. 
 
Figure 12. Animal 4’s amebocyte profile, show a correlation between the recovery of amebocyte density 
and a shift in the discrete profiles toward smaller diameter amebocytes.  
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6 FUTURE RESEARCH 
 
6.1 Replication of Current Methods 
To further support the data from this research, using more replicates is necessary. 
Additionally, for this research, all but one animal was male, which may misrepresent the 
population as a whole. Because males were used in this study, there is no way of knowing 
if some variation between the sexes exists with respect to: amebocyte density, diameter, 
and regeneration rate. This study used matched sizing of smaller animals potentially 
limiting some variability in the data. Therefore, a larger range of animal size should be 
utilized since it may result in a different range of amebocyte diameters.  
 
6.2 Sensitivity Testing 
 After providing a profile for the amebocyte production in the American 
Horseshoe Crab, subsequent quantification of amebocyte sensitivity would provide a 
means of comparing the sensitivity of cultured amebocytes to those harvested from the 
hemolymph. A protocol outlining the creation of endotoxin standards via dilutions of E. 
coli should be established. These endotoxin standards can then be used find the average 
clotting time for amebocytes in the presence of various endotoxin concentrations. Upon 
finding baseline sensitivities, a series of large bleeds should be performed and the 
hemolymph should be tested for changes in sensitivity as the amebocyte density 
decreases and is repopulated by new amebocytes. This understanding of amebocyte 
sensitivities will provide a means to test whether amebocytes grown in-vitro can be as or 
more effective at producing LAL than those harvested from the hemolymph. 
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6.3 Comparison to Amebocytes Grown In-Vitro  
 Upon successful completion of the two previous aims, a series of gill lamellae 
cultures can be grown and observed for amebocyte production. After successful growth, 
they can be tested for comparable sensitivity to amebocytes produced in a living animal. 
If the amebocytes from the in-vitro cultures are comparable in density per milliliter, 
diameter, and sensitivity to those in the hemolymph, they may be collected and used for 
the production of LAL. Upon confirmation of amebocytes usable for LAL production, 
then a method for upregulating the production of amebocytes can be attempted. In order 
for in-vitro cultures to replace current LAL production methods the in-vitro production of 
amebocytes must produce substantial enough quantities as compared to the levels 
currently produced by the LAL industry.   
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7 CONCLUSION 
 
  The results from this study show that the amebocyte density and diameter range 
from 1-3 x 107 amebocytes per ml and from nine to twelve µm in diameter for animals in 
the weight range of 500-800 grams. When forty to fifty percent of the hemolymph is 
removed, hemolymph volumes recover within twelve days to within two percent of the 
baseline weight. After twenty-four days the density recovers to within five percent of the 
baseline value. The amebocyte diameter recovers to within one percent of the  baseline 
value after thirty days following the large hemolymph removal.    
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APPENDIX 
 
A Additional Methods 
 
A.1 Preparation of Solutions 
The preparation of an anti-clotting agent was attempted to prolong the storage 
period of the hemolymph sample. Through study of the literature and industry standards 
it was suggested that the presence N-ethylmaleimide would aid in preventing amebocyte 
degranulation. After purchasing the N-ethylmaleimide it was mixed with deionized water 
and sodium chloride to achieve a solution with .125% N-ethylmaleimide and 3% sodium 
chloride. Hydrochloric acid and additional sodium chloride was used when necessary to 
make the solution have a pH of 7.4, equivalent to that of the hemolymph.  The solution 
was made in 100 mL quantities and stored in a previously sterilized Wheaton bottle. 
Initial testing showed an allotment of up to an hour of expanded storage life. As time 
passed, the solution lost effectiveness; even when the solution was made again, there was 
little to no difference in clotting speeds with and without the solution. Importantly, use of 
the anti-clotting chemical was discontinued because the chemical caused the amebocytes 
to swell, skewing the amebocyte profiles.    
 
A.3 Alternate Methods for Estimating Amebocyte Diameter Profiles 
Since there was no industry standard for determining the average amebocyte 
diameter in each animal, three separate methods were attempted. The first method 
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utilized a technique suggested by Dr. Ella Ingram which required the use of photographs 
taken under 400X magnification. Enough pictures to view fifty amebocytes were printed, 
and individual amebocytes were cut out using a scalpel. Each amebocyte was then 
measured and weighed. A series of conversion factors were used to check this method: 
the ratio of amebocyte weight to a known dimension of weighed paper, a ratio between a 
known size square and the amebocyte measurements, and a direct conversion using the 
magnifications were all used. Although this is a well established method other proved to 
be less time consuming. 
 The second method utilized the Paint program on a laptop and the 100X 
magnified pictures. The pictures were then magnified to 800% and a grid was added to 
the pictures. For fifty amebocytes the diameter was measured by counting the number of 
grid boxes from one side of the amebocyte to the other. The diameter was corrected for 
by using a ratio of the known and measured size of a box from the hemacytometer. This 
method, although tedious, produced consistent results with the methods used in this 
study. 
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B Additional Animal Data 
 
This appendices is a collection of all tables and figures for the additional animals used in the experiment 
but not directly discussed in the results or discussion. Tables from the statistical analysis of the baseline 
information for intra and interanimal comparisons are also contained here.  
B.1 Amebocyte Density Figures and Statistical Tables 
Table 6. Variablity was seen between days of the baseline bleed series suggesting sampling error, unknown 
variables, or uncontrollable variables occurred during the small bleeds. 
Animal Date N Mean (amebocytes x 107 /ml) StDev. F P Tukey Grouping 
1  48 1.98 0.45 4.07 0.012  
 8-2 12 1.99 0.33   A, B 
 8-4 12 2.26 0.27   A 
 8-9 12 1.68 0.58   B 
 8-11 12 1.97 0.39   A, B 
2   48 2.34 0.60 0.65 0.59  
 8-3 12 2.28 0.77   A 
 8-5 12 2.45 0.88   A 
 8-10 12 2.46 0.22   A 
 8-12 12 2.17 0.23   A 
3  48 1.09 0.50 19.13 0.000  
 8-3 12 1.38 0.22   A 
 8-5 12 0.93 0.13   B 
 8-10 12 0.92 0.16   B 
 8-12 12 1.14 0.16   C 
4  36 1.71 0.54 33.57 0.000  
 8-2 12 1.40 0.29   A 
 8-4       
 8-9 12 2.33 0.43   B 
 8-11 12 1.41 0.19   A 
5   48 1.81 0.30 11.66 0.000  
 8-2 12 1.50 0.27   A 
 8-4 12 1.85 0.30   B 
 8-9 12 1.81 0.15   B 
 8-11 12 2.05 0.16   B 
6   48 1.51 0.54 8.05 0.000  
 8-3 12 1.13 0.45   A 
 8-5 12 2.01 0.73   B 
 8-10 12 1.44 0.22   A 
 8-12 12 1.44 0.15   A 
7  42 2.85 0.73 7.18 0.001  
 8-3 12 3.15 0.46   A,B 
 8-5 12 2.34 0.17   C 
 8-10 6 3.60 0.33   A 
 8-12 12 2.68 0.99   B,C 
8  48 2.25 0.35 15.96 0.000  
 8-2 12 1.72 0.29   A 
 8-4 12 2.43 0.38   B 
 8-9 12 2.39 0.24   B 
 8-11 12 2.45 0.30   B 
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Table 7. Comparing the baseline amebocyte density for eight animals shows significant variability between 
the animals.  
Animal N Mean 
(amebocytes x 107 /ml) 
Std F P Tukey Group 
1 48 1.98 0.45   C,D 
2 36 2.34 0.60   B 
3 48 1.09 0.25   F 
4 48 1.71 0.54   D,E 
5 48 1.81 0.30   D,E 
6 48 1.51 0.54   E 
7 48 2.85 0.73   A 
8 42 2.25 0.43   B,C 
 366 1.93 0.71 54.18 0.000  
 
Figure 13. Animal 1 showed an amebocyte density decrease at day four followed by a dramatic increase on 
day ten. 
Table 8. Animal 1’s Amebocyte density dropped below average three days after the large hemolymph 
removal and increased to above average on day ten. 
Time (days) N 
Mean Density 
(amebocytes x 107 /ml)
 
StDev
 
SE Mean
 
P 
Baseline 48 1.98E+07 4.49E+06 6.48E+05 1.00 
4 6 1.07E+07 5.72E+06 2.33E+06 0.01 
6 6 2.92E+06 1.29E+06 5.27E+05 0.00 
8 6 1.35E+07 3.04E+06 1.24E+06 0.00 
10 6 2.68E+07 4.91E+06 2.00E+06 0.02 
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Figure 14. Animal 2’s amebocyte density decreased below the baseline mean at day five and recovered by 
day eighteen. 
Table 9. Animal 2’s amebocyte density statistically drops below the baseline mean after day three and 
returns to baseline mean by day fourteen after the large hemolymph removal. 
Time (days) N 
Mean Density 
(amebocytes x 107 /ml) StDev SE Mean P 
Baseline 48 2.34E+07 5.97E+06 8.62E+05 1.00 
3 6 2.01E+07 5.53E+06 2.26E+06 0.21 
5 6 6.71E+06 9.24E+06 3.77E+06 0.01 
8 6 1.09E+07 8.61E+05 3.52E+05 0.00 
11 6 1.45E+07 1.58E+06 6.44E+05 0.00 
14 5 1.58E+07 7.70E+06 3.44E+06 0.09 
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Figure 15. Animal 3’s sees an initial decrease in amebocyte density on day three followed by an return to 
the baseline mean at by eight. 
Table 10. The one-sample t-test with the baseline mean as the hypothesis shows the amebocyte density 
dropped below the baseline mean at day three and recovered by day eight. 
Time (days) N 
Mean Density 
(amebocytes x 107 /ml) StDev SE Mean P 
Baseline 48 1.09E+07 2.50E+06 3.61E+05 1.00 
3 6 3.29E+06 7.65E+05 3.12E+05 0.00 
5 6 6.17E+06 5.40E+05 2.20E+05 0.00 
8 6 9.96E+06 1.31E+06 5.34E+05 0.13 
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B.2 Amebocyte Diameter Figures and Statistical Tables 
 
Table 11. A one-way unstacked ANOVA showed variation between the four bleeds that made up the 
baseline data suggesting some mechanism in the animal or from the bleed causing variability. 
Animal Date N Mean Diameter (µm) StDev. F P Tukey Grouping 
1  400 11.02 1.54 6.18 0.000  
 8-2 100 11.18 1.36   A 
 8-4 100 11.38 1.52   A 
 8-9 100 11.05 1.44   A 
 8-11 100 10.48 1.72   B 
2   400 10.48 1.69 5.54 0.001  
 8-3 100 10.99 2.04   A 
 8-5 100 10.51 1.59   A,B 
 8-10 100 10.55 1.36   A,B 
 8-12 100 9.95 1.57   B 
3  400 9.55 1.84 2.09 0.101  
 8-3 100 9.66 2.06   A 
 8-5 100 9.60 1.93   A 
 8-10 100 9.79 1.60   A 
 8-12 100 9.18 1.69   A 
4  300 11.52 1.52 3.89 0.009  
 8-2 100 11.15 1.57   A 
 8-4 50 11.95 1.92   B 
 8-9 100 11.54 1.32   A,B 
 8-11 50 11.79 1.18   A,B 
5  400 11.68 1.81 7.47 0.000  
 8-2 100 11.42 1.82   A 
 8-4 100 12.39 1.65   B 
 8-9 100 11.35 2.01   A 
 8-11 100 11.57 1.56   A 
6  400 9.49 1.58 12.61 0.000  
 8-3 100 9.00 1.65   A 
 8-5 100 9.24 1.62   A 
 8-10 100 9.46 1.29   A 
 8-12 100 10.25 1.50   B 
7  350 9.85 1.77 6.23 0.000  
 8-3 100 10.16 2.10   A 
 8-5 100 9.23 1.92   A 
 8-10 50 10.23 1.09   B 
 8-12 100 9.97 1.36   A 
8  350 10.86 1.75 17.43 0.000  
 8-2 100 11.18 1.97   A 
 8-4 50 9.35 2.06   B 
 8-9 100 11.26 1.31   A 
 8-11 100 10.91 1.30   A 
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Table 12. The eight animals, used in the baseline series, showed variation between one another for the 
average amebocyte diameter. 
Animal N Mean Diameter (µm) Std F P Tukey Group 
1 400 11.02 1.54   B 
2 400 10.48 1.69   C 
3 400 9.55 1.84   D 
4 300 11.52 1.52   A 
5 400 11.68 1.81   A 
6 400 9.49 1.58   D 
7 350 9.85 1.77   D 
8 350 10.86 1.75   B 
 3000 10.53 1.87 96.35 0.000  
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Table 13. The amebocyte diameter of Animal 1 significantly decreased after the large hemolymph removal 
after three weeks the diameter began recovering but never reestablished the same diameter mean as the 
baseline.  
Time (days) N Mean Diameter (µm) StDev SE Mean P 
Baseline 309 11.19 1.46 0.08 1.00 
4 51 9.25 1.65 0.23 0.00 
6 51 9.06 1.78 0.25 0.00 
8 51 8.46 1.65 0.23 0.00 
10 51 9.76 1.64 0.23 0.00 
18 51 10.05 1.55 0.22 0.00 
28 51 9.63 1.38 0.19 0.00 
35 51 10.45 1.60 0.23 0.00 
42 51 10.12 1.40 0.20 0.00 
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Figure 16. Animal 1’s amebocyte diameter decrease below the baseline mean day three after the large 
hemolymph removal and although the distribution of the cells changed the diameter never recovered. 
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Table 14. Animal 2 shows a decrease in mean amebocyte diameter from day three after the large 
hemolymph removal to day eighteen. 
Time (days) N Mean Diameter (µm) StDev SE Mean P 
Baseline 400 10.48 1.69 0.08 0.97 
3 51 9.38 1.83 0.26 0.00 
5 51 9.26 1.31 0.18 0.00 
8 51 8.25 1.55 0.22 0.00 
11 51 9.04 1.62 0.23 0.00 
14 51 8.78 1.52 0.21 0.00 
18 51 10.54 2.03 0.29 0.85 
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Figure 17. Animal 2’s baseline diameter decreases and changes distribution compared to the baseline on
day three and returns to the baseline mean by day eighteen. 
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Table 15. Animal 3’s mean amebocyte diameter varied from the baseline value on day eighteen after the 
large hemolymph removal. There was a second change in diameter beginning day twenty-eight and 
returning the baseline value by day forty-two. 
Time (days) N Mean Diameter (µm) StDev SE Mean P 
Baseline 400 9.55 1.84 0.09 0.96 
18 51 10.14 1.82 0.26 0.02 
21 51 9.68 2.19 0.31 0.67 
25 51 9.39 1.62 0.23 0.48 
28 51 11.14 1.94 0.27 0.00 
35 51 10.95 1.73 0.24 0.00 
42 51 9.88 1.93 0.27 0.24 
49 51 10.11 1.57 0.22 0.01 
56 51 9.53 1.67 0.23 0.92 
63 51 9.98 1.70 0.24 0.08 
73 51 10.01 1.52 0.21 0.04 
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Figure 18. Animal 3’s distribution and average diameter varied from the baseline values on day twenty-
eight returning by day forty-two. 
